EGFR+ NSCLC

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

EGFR+ NSCLC
Jan 7, 2025, 13:33 | Insight
5 papers about Lung Cancer suggested by Stephen Liu
Stephen Liu, Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a few must-reads papers…
Dec 25, 2024, 02:57 | Insight
Jarushka Naidoo: Important paper on incidence and outcomes of EGFR+ NSCLC
Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin (Ireland), posted the following on X:…
Nov 11, 2024, 10:19 | Blog
Eric Singhi: The ever-evolving 1st line treatment landscape of metastatic EGFR+ NSCLC
Eric Singhi, Assistant Professor at The University of Texas MD Anderson Cancer Center, shared a…
Nov 1, 2024, 08:03 | Blog
Stephen Liu: Discussion on first-line management of EGFR NSCLC with Zosia Piotrowska
Stephen Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi…
Oct 9, 2024, 15:23 | Blog
Upal Basu Roy: How immune cells can be engineered to target EGFR+ NSCLC
Upal Basu Roy, Executive Director of Research at LUNGevity Foundation, shared about a Facebook Live…
Oct 7, 2024, 15:38 | Insight
Stephen V Liu: Afatinib and Bevacizumab in EGFR NSCLC
Stephen V Liu posted the following on X: “Phase II ABCD study of afatinib and…
Sep 11, 2024, 01:59 | Societies
38 Posts Not to Miss From WCLC24 Day 3!
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Aug 23, 2024, 14:21 | Drugs
Stephen V Liu: How do we select the optimal regimen for EGFR NSCLC?
Stephen V Liu shared on X: "With FLAURA (osimertinib alone), FLAURA2 (osimertinib with chemotherapy), and…
Aug 20, 2024, 13:48 | Insight
Stephen Liu: So many great WCLC24 sessions to choose from
Stephen Liu shared a post on X: “So many great WCLC24 sessions to choose from.…
Jun 10, 2024, 11:09 | Insight
Phase II BLOSSOM Trial Osimertinib in LMD from EGFR+ NSCLC by Sehhoon Park et al.
Jarushka Naidoo shared a post on X: "Phase II BLOSSOM Trial Osimertinib in LMD (leptomeningeal…
All: 10 Posts: 1 - 100
Special Coverage